Modified combination of anti-thymocyte globulin (ATG) and post-transplant cyclophosphamide (PTCy) as compared with standard ATG protocol in haploidentical peripheral blood stem cell transplantation for acute leukemia.

Barkhordar, Maryam; Kasaeian, Amir; Janbabai, Ghasem; Kamranzadeh Fumani, Hossein; Tavakoli, Sahar; Rashidi, Amir Abbas; Mousavi, Seied Asadollah; Ghavamzadeh, Ardeshir; Vaezi, Mohammad

Barkhordar, Maryam; Kasaeian, Amir; Janbabai, Ghasem; Kamranzadeh Fumani, Hossein; Tavakoli, Sahar; Rashidi, Amir Abbas; Mousavi, Seied Asadollah; Ghavamzadeh, Ardeshir; Vaezi, Mohammad.

Afiliación

Barkhordar M; Hematology, Oncology and Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
Kasaeian A; Hematology, Oncology and Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
Janbabai G; Digestive Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Kamranzadeh Fumani H; Inflammation Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Tavakoli S; Hematology, Oncology and Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
Rashidi AA; Hematology, Oncology and Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
Mousavi SA; Hematology, Oncology and Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
Ghavamzadeh A; Hematology, Oncology and Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
Vaezi M; Hematology, Oncology and Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.

Front Immunol ; 13: 921293, 2022.

Article en En | MEDLINE | ID: mdl-35990618

Asunto(s)

Enfermedad Injerto contra Huésped; Trasplante de Células Madre Hematopoyéticas; Leucemia Mieloide Aguda; Trasplante de Células Madre de Sangre Periférica; Adulto; Suero Antilinfocítico/uso terapéutico; Ciclofosfamida/uso terapéutico; Enfermedad Injerto contra Huésped/etiología; Enfermedad Injerto contra Huésped/prevención & control; Trasplante de Células Madre Hematopoyéticas/efectos adversos; Humanos; Trasplante de Células Madre de Sangre Periférica/efectos adversos; Estudios Retrospectivos

Palabras clave

Graft versus host disease (GvHD); acute leukemia (AL); anti-thymocyte globulin (ATG); haploidentical stem cell transplantation (HSCT); peripheral blood stem cells (PBSCs); post-transplantation cyclophosphamide (PTCy)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Trasplante de Células Madre Hematopoyéticas / Trasplante de Células Madre de Sangre Periférica / Enfermedad Injerto contra Huésped Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google